Induction at 39 Weeks for Low-Risk Nulliparous Women
For low-risk nulliparous women, elective induction of labor at 39 weeks (39+0 to 39+4) is reasonable and reduces cesarean delivery rates and hypertensive disorders without increasing perinatal morbidity compared to expectant management. 1
Evidence-Based Timing by Clinical Scenario
Low-Risk Nulliparous Women (No Risk Factors)
The SMFM guideline based on the landmark ARRIVE trial provides clear direction: offer elective induction at 39+0 to 39+4 weeks 1. This approach:
- Reduces cesarean delivery from 22.2% to 18.6% (NNT = 28 to prevent one cesarean) 1
- Reduces hypertensive disorders from 14.1% to 9.1% 1
- Shows no significant difference in perinatal death or severe neonatal morbidity (4.3% vs 5.4%, though trending toward benefit) 1
Critical implementation requirements 1:
- Dating must be confirmed by early ultrasound (<21 weeks if certain LMP, first trimester if uncertain LMP)
- Patient must meet ARRIVE eligibility: nulliparous, singleton, no medical/obstetric complications
- Cervical favorability does NOT matter (63% had unfavorable cervix in ARRIVE)
- Allow ≥12 hours after cervical ripening before declaring failed induction
Women with Prior Stillbirth
Induction at 39 weeks is strongly recommended 2. The most recent 2025 BJOG guideline states there is "enough evidence to consider and discuss induction of labour or birth by 39 weeks of gestation" in subsequent pregnancies after late intrauterine fetal death 2.
The evidence shows:
- Perinatal outcomes after induction are optimal at 39-41 weeks 2
- Induction at 37-38 weeks increases perinatal morbidity 2
- Earlier delivery may be warranted if the prior stillbirth occurred earlier or if additional risk factors exist (cholestasis, preeclampsia, insulin-dependent diabetes) 2
Advanced Maternal Age (≥35 years, especially ≥40 years)
Induction at 39 weeks is recommended 2. The 2025 BJOG guideline specifically cites the 35/39 trial showing that for women over 35 years, routine induction at 39 weeks prevents stillbirths without increasing cesarean rates 2.
For women ≥40 years, the data are particularly compelling 3:
- Hazard risk of stillbirth doubles from 39 to 40 weeks (0.60 to 1.16 per 1000)
- Relative risk at 40 weeks is 5.17 (95% CI 3.16-8.46) in this age group
- Induction at 39 weeks could prevent 7.3% of stillbirths in women ≥40 years
Importantly, induction does not increase cesarean rates in advanced maternal age when compared to expectant management 4.
Induction at 41 Weeks (If Not Induced Earlier)
If a woman reaches 41 weeks undelivered, induction at 41+0 to 41+3 weeks is preferable to waiting longer 5, 6:
- At 41+0 to 41+1 weeks: Reduces stillbirth (aOR 0.15,95% CI 0.05-0.51) but increases cesarean rates (aOR 1.42) 6
- At 41+2 to 41+3 weeks: Reduces perinatal mortality (aOR 0.13,95% CI 0.04-0.43) 6
- At 41+4 to 41+5 weeks: Still reduces stillbirth (aOR 0.30) but with higher cesarean rates 6
The Finnish RCT comparing induction at 41+0 vs 41+5 to 42+1 weeks showed lower operative delivery rates with earlier induction (30.6% vs 45.6%, p=0.003), though 45.6% of expectantly managed women achieved spontaneous labor 5.
Clinical Algorithm
Step 1: Confirm accurate dating
- Early ultrasound (<21 weeks or first trimester) is mandatory before offering elective induction at 39 weeks
Step 2: Risk stratification
- High-risk groups (prior stillbirth, age ≥40, specific medical conditions): Strongly recommend induction at 39+0 to 39+4 weeks
- Low-risk nulliparous: Offer induction at 39+0 to 39+4 weeks with shared decision-making
- Multiparous low-risk: Evidence is insufficient; ARRIVE findings may not extrapolate 1
Step 3: If patient declines or reaches 41 weeks
- Counsel for induction at 41+0 to 41+3 weeks (optimal balance of stillbirth reduction vs cesarean risk)
- All women should be delivered by 42+2 weeks 1
Common Pitfalls to Avoid
Inducing before 39 weeks without indication: Early term delivery (37-38 weeks) increases respiratory morbidity 1
Declaring failed induction prematurely: Must allow ≥12 hours after cervical ripening completion before cesarean for "failed induction" 1
Refusing induction due to unfavorable cervix: 63% of ARRIVE participants had unfavorable cervix; use cervical ripening agents 1
Assuming multiparous women have same benefit: ARRIVE only studied nulliparous women; extrapolation is uncertain 1
Overlooking the importance of accurate dating: Inaccurate dating risks iatrogenic prematurity 1
Nuances in Shared Decision-Making
Both elective induction at 39 weeks and expectant management are reasonable options for low-risk nulliparous women 1. Some women prioritize:
- Lower cesarean risk and hypertensive disorders → favor induction
- Possibility of spontaneous labor → favor expectant management
However, for women with risk factors (prior stillbirth, advanced maternal age), the balance shifts strongly toward induction at 39 weeks given mortality/morbidity benefits 2, 3.